نتایج جستجو برای: recombinant erythropoietin red cell metabolism

تعداد نتایج: 2036318  

Journal: :Annals of clinical and laboratory science 1981
C L Sexauer J R Matson

Anemia is one of the most characteristic and visable manifestations of chronic renal failure. Investigators in the past decade have provided a better understanding of this anemia. The etiology of the anemia of chronic renal failure has three facets: first is reduced erythropoietin production by damaged kidneys; second is the presence of inhibitors to red blood cell (RBC) production in uremic se...

Journal: :Journal of the American Society of Nephrology : JASN 2004
Denis Cournoyer Edwin B Toffelmire George A Wells Dwayne L Barber Brendan J Barrett Robert Delage Donna L Forrest Raymonde F Gagnon Elizabeth A Harvey Pierre Laneuville Bruce J Patterson Man-Chiu Poon Gerald A Posen Hans A Messner

Since 1998, there has been a marked increase in incidence of pure red cell aplasia secondary to development of anti-erythropoietin antibodies (Ab+ PRCA) in patients who have chronic kidney disease (CKD) and receive recombinant erythropoietin. The relationship between incidence of Ab+ PRCA and specific erythropoietin products has not been examined rigorously. Manufacturers provided data regardin...

2012
Mawadda Alnaeeli Li Wang Barbora Piknova Heather Rogers Xiaoxia Li Constance Tom Noguchi

Erythropoietin is known as the requisite cytokine for red blood cell production. Its receptor, expressed at a high level on erythroid progenitor/precursor cells, is also found on endothelial, neural, and other cell types. Erythropoietin and erythropoietin receptor expression in the developing and adult brain suggest their possible involvement in neurodevelopment and neuroprotection. During isch...

Journal: :Critical Care 2004
Martin Darveau André Y Denault Normand Blais Éric Notebaert

Critically ill patients frequently develop anemia due to several factors. Iron-withholding mechanisms caused by inflammation contribute to this anemia. The iron metabolism imbalances described or reported in all intensive care studies are similar to the values observed in anemia of inflammation. The administration of iron could be useful in the optimization of recombinant human erythropoietin a...

Journal: :Journal of the American Society of Nephrology 2004

Journal: :Blood 2006
Monique Beullens Joris R Delanghe Mathieu Bollen

Erythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEPO in urine. The adopted test is based on a combination of isoelectric focusing and double immunoblotting, and distinguishes between endogeno...

2006
Monique Beullens Joris R. Delanghe Mathieu Bollen

Erythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEPO in urine. The adopted test is based on a combination of isoelectric focusing and double immunoblotting, and distinguishes between endogeno...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید